Hansa Investment Company Limited
03 August 2026
Hansa Investment Company Limited
At close of business on 31st July 2026 the Company held the following investments with a value greater than 5% of gross assets or were at least the 10 largest holdings, a declaration of which is required quarterly under the Listing Rules; however Hansa Investment Company Limited has decided to declare this information on a monthly basis:
|
% |
|
|
iShares Core S&P 500 UCITS ETF |
12.2 |
|
Life Cycle US Equity Fund - UCITS |
5.1 |
|
Polar Capital Global Technology Fund |
4.2 |
|
Helikon Long Short Equity Fund ICAV |
3.5 |
|
iShares Core MSCI Europe UCITS ETF |
3.4 |
|
iShares Expanded Tech Sector ETF |
3.2 |
|
Schroder ISF Asian Total Return |
3.0 |
|
BlackRock Strategic Equity Hedge Fund |
2.8 |
|
Findlay Park American Fund |
2.7 |
|
Schroder ISF Global Recovery |
2.6 |
|
Total |
42.6 |
|
Cash (including liquidity funds)* |
6.5 |
*The cash from the sale of Wilson Sons is being deployed quarterly over one year, subject to the Investment Advisor's discretion. The first, second and third tranches were deployed in December 2025, March 2026 and June 2026, respectively.
Hansa Capital Partners LLP
Additional Administrative Services Provider to Hansa Investment Company Limited
020 7647 5750
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.